EMEA-001645-PIP01-14-M02

  • Email
  • Help

Overview

Product details for Zinplava
Invented nameZinplava
Active substance

Bezlotoxumab

Decision numberP/0387/2017
PIP numberEMEA-001645-PIP01-14-M02
Pharmaceutical form(s)Concentrate for solution for infusion
Condition(s)/indication(s)

Treatment of Clostridium difficile infection

Route(s) of administrationIntravenous use
PIP applicant

Merck Sharp & Dohme (Europe), Inc.
Tel. +31 412663179
E-mail: pip.information@merck.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision

Related information

Related information